Literature DB >> 7207014

Morphine is most effective on gastrointestinal propulsion in rats by intraperitoneal route: evidence for local action.

A Tavani, G Bianchi, P Ferretti, L Manara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7207014     DOI： 10.1016/0024-3205(80)90386-0

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  12 in total

Review 1.  Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.

Authors:  Antonio Gatti; Alessandro Fabrizio Sabato
Journal:  Clin Drug Investig       Date:  2012-05-01       Impact factor: 2.859

Review 2.  [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].

Authors:  S Bader; M Weber; G Becker
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

Review 3.  Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.

Authors:  Richard L Rauck
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

4.  Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.

Authors:  G Basilisco; A Bozzani; G Camboni; M Recchia; M Quatrini; D Conte; R Penagini; P A Bianchi
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

5.  Managing opioid-induced constipation in advanced illness: focus on methylnaltrexone bromide.

Authors:  Katri Elina Clemens; Eberhard Klaschik
Journal:  Ther Clin Risk Manag       Date:  2010-03-03       Impact factor: 2.423

6.  [Oral administration of slow-release naloxone for prevention of constipation but not analgesia following oral morphine.].

Authors:  I Jurna; J Baldauf
Journal:  Schmerz       Date:  1993-12       Impact factor: 1.107

7.  Design, synthesis, and biological evaluation of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives as peripheral selective μ opioid receptor Agents.

Authors:  Yunyun Yuan; Orgil Elbegdorj; Jianyang Chen; Shashidhar K Akubathini; Feng Zhang; David L Stevens; Irina O Beletskaya; Krista L Scoggins; Zhenxian Zhang; Phillip M Gerk; Dana E Selley; Hamid I Akbarali; William L Dewey; Yan Zhang
Journal:  J Med Chem       Date:  2012-11-09       Impact factor: 7.446

8.  Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.

Authors:  M G De Simoni; V Guardabasso; K Misterek; S Algeri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

9.  Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromide.

Authors:  S Bader; K Jaroslawski; H E Blum; G Becker
Journal:  Clin Med Insights Oncol       Date:  2011-07-14

10.  Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.

Authors:  Lynn R Webster; Darren M Brenner; Andrew C Barrett; Craig Paterson; Enoch Bortey; William P Forbes
Journal:  J Pain Res       Date:  2015-10-30       Impact factor: 3.133
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.